abt 702 has been researched along with Ache in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cowart, M | 1 |
Lee, CH | 2 |
Gfesser, GA | 1 |
Bayburt, EK | 1 |
Bhagwat, SS | 2 |
Stewart, AO | 1 |
Yu, H | 1 |
Kohlhaas, KL | 1 |
McGaraughty, S | 1 |
Wismer, CT | 2 |
Mikusa, J | 2 |
Zhu, C | 1 |
Alexander, KM | 1 |
Jarvis, MF | 3 |
Kowaluk, EA | 3 |
Zhu, CZ | 1 |
Schweitzer, E | 1 |
Lynch, JJ | 1 |
Jiang, M | 1 |
Gomtsyan, A | 1 |
McKie, J | 1 |
Cox, BF | 1 |
Polakowski, J | 1 |
Reinhart, G | 1 |
Williams, M | 2 |
Suzuki, R | 1 |
Stanfa, LC | 1 |
Dickenson, AH | 1 |
3 other studies available for abt 702 and Ache
Article | Year |
---|---|
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
Topics: Adenosine Kinase; Administration, Oral; Animals; Cell Membrane Permeability; Enzyme Inhibitors; Hype | 2001 |
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Topics: Adenosine Kinase; Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, | 2000 |
The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.
Topics: Adenosine Kinase; Animals; Behavior, Animal; Carrageenan; Dose-Response Relationship, Drug; Electrop | 2001 |